MY200184A - Biomarker - Google Patents
BiomarkerInfo
- Publication number
- MY200184A MY200184A MYPI2020001473A MYPI2020001473A MY200184A MY 200184 A MY200184 A MY 200184A MY PI2020001473 A MYPI2020001473 A MY PI2020001473A MY PI2020001473 A MYPI2020001473 A MY PI2020001473A MY 200184 A MY200184 A MY 200184A
- Authority
- MY
- Malaysia
- Prior art keywords
- biomarker
- analysing
- huntington
- als
- disease
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title 1
- 210000000349 chromosome Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762566756P | 2017-10-02 | 2017-10-02 | |
| PCT/GB2018/052808 WO2019069067A1 (en) | 2017-10-02 | 2018-10-01 | BIOMARKER |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY200184A true MY200184A (en) | 2023-12-12 |
Family
ID=63834322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2020001473A MY200184A (en) | 2017-10-02 | 2018-10-01 | Biomarker |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12006547B2 (OSRAM) |
| EP (1) | EP3692168A1 (OSRAM) |
| JP (2) | JP2020537514A (OSRAM) |
| KR (1) | KR102762920B1 (OSRAM) |
| CN (1) | CN111344415B (OSRAM) |
| AU (1) | AU2018344573B2 (OSRAM) |
| CA (1) | CA3076450A1 (OSRAM) |
| MY (1) | MY200184A (OSRAM) |
| SG (1) | SG11202002503TA (OSRAM) |
| WO (1) | WO2019069067A1 (OSRAM) |
| ZA (1) | ZA202001821B (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2604247B (en) * | 2019-09-11 | 2025-07-02 | Oxford BioDynamics PLC | Diagnostic chromosome marker |
| GB202016176D0 (en) * | 2020-10-12 | 2020-11-25 | Oxford BioDynamics PLC | Disease marker |
| AU2022206099B2 (en) * | 2021-01-07 | 2023-08-10 | Oxford BioDynamics PLC | Chromosome interactions |
| CN117203350A (zh) * | 2021-01-07 | 2023-12-08 | 牛津生物动力公共有限公司 | 染色体相互作用 |
| CN113035298B (zh) * | 2021-04-02 | 2023-06-20 | 南京信息工程大学 | 递归生成大阶数行限制覆盖阵列的药物临床试验设计方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2116280A1 (en) * | 1993-03-05 | 1994-09-06 | Marcy E. Macdonald | Huntingtin dna, protein and uses thereof |
| BRPI0611702B1 (pt) * | 2005-07-04 | 2015-05-19 | Univ Erasmus Medical Ct | Captura e caracterização de cromatina co-localizada (4c) |
| GB0810051D0 (en) * | 2008-06-02 | 2008-07-09 | Oxford Biodynamics Ltd | Method of diagnosis |
| JP5503942B2 (ja) * | 2009-10-30 | 2014-05-28 | シスメックス株式会社 | 疾患の罹患の判定方法 |
| WO2012159025A2 (en) * | 2011-05-18 | 2012-11-22 | Life Technologies Corporation | Chromosome conformation analysis |
| US11795496B2 (en) | 2015-06-24 | 2023-10-24 | Oxford BioDynamics PLC | Epigenetic chromosome interactions |
| WO2017001568A1 (en) | 2015-07-01 | 2017-01-05 | Universitat De Lleida | Treatment and prevention of amyotrophic lateral sclerosis |
| JP7045086B2 (ja) | 2016-12-23 | 2022-03-31 | オックスフォード バイオダイナミックス パブリック リミテッド カンパニー | 分類法 |
-
2018
- 2018-10-01 WO PCT/GB2018/052808 patent/WO2019069067A1/en not_active Ceased
- 2018-10-01 SG SG11202002503TA patent/SG11202002503TA/en unknown
- 2018-10-01 US US16/652,959 patent/US12006547B2/en active Active
- 2018-10-01 EP EP18785703.2A patent/EP3692168A1/en active Pending
- 2018-10-01 AU AU2018344573A patent/AU2018344573B2/en active Active
- 2018-10-01 MY MYPI2020001473A patent/MY200184A/en unknown
- 2018-10-01 KR KR1020207012372A patent/KR102762920B1/ko active Active
- 2018-10-01 JP JP2020518706A patent/JP2020537514A/ja active Pending
- 2018-10-01 CA CA3076450A patent/CA3076450A1/en active Pending
- 2018-10-01 CN CN201880074086.9A patent/CN111344415B/zh active Active
-
2020
- 2020-03-23 ZA ZA2020/01821A patent/ZA202001821B/en unknown
-
2023
- 2023-09-07 JP JP2023145557A patent/JP7701419B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7701419B2 (ja) | 2025-07-01 |
| US12006547B2 (en) | 2024-06-11 |
| KR102762920B1 (ko) | 2025-02-04 |
| NZ762713A (en) | 2025-03-28 |
| JP2023182591A (ja) | 2023-12-26 |
| KR20200058527A (ko) | 2020-05-27 |
| AU2018344573A1 (en) | 2020-04-09 |
| JP2020537514A (ja) | 2020-12-24 |
| WO2019069067A1 (en) | 2019-04-11 |
| CN111344415A (zh) | 2020-06-26 |
| CN111344415B (zh) | 2024-04-30 |
| US20200407790A1 (en) | 2020-12-31 |
| AU2018344573B2 (en) | 2020-09-17 |
| ZA202001821B (en) | 2022-10-26 |
| SG11202002503TA (en) | 2020-04-29 |
| EP3692168A1 (en) | 2020-08-12 |
| CA3076450A1 (en) | 2019-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY207247A (en) | Detection of chromosome interaction relevant to breast cancer | |
| TWD170641S (zh) | 生物感測器腕帶 | |
| SG10201900574SA (en) | Virtual currency conversion device, method and computer program | |
| IL246908A0 (en) | Ideograms are based on sentiment analysis | |
| EP4524972A3 (en) | Analysis of genetic variants | |
| EP3201757A4 (en) | Identifying temporal demand for autocomplete search results | |
| MA40325A (fr) | Procédés et compositions pour diagnostiquer, pronostiquer et confirmer une pré-éclampsie. | |
| IN2014DN09302A (OSRAM) | ||
| EP3103018A4 (en) | Method for debugging computer program | |
| EP3524689A4 (en) | METHOD FOR PROGNOSING BREAST CANCER PATIENTS | |
| BR112014029608A2 (pt) | cigarro com ponta de filtro com tampa removível, e respectivos método e máquina para sua fabricação | |
| WO2016023991A8 (de) | Verfahren zur mikrobiom-analyse | |
| EP3666729C0 (en) | PROCESS FOR THE PRODUCTION OF NANO-SULFUR | |
| EP3201359A4 (en) | Methods for analyzing samples | |
| EP3098311A4 (en) | Method for measuring modified nucleobase using guide probe, and kit therefor | |
| MX2016007310A (es) | Sistema y metodo para determinar las propiedades biometricas de un ojo. | |
| EP3167080A4 (en) | Genetic addiction risk analysis for rds severity index | |
| EP3217690A4 (en) | Method and apparatus for determining to suspend service, and method and apparatus for processing instruction information | |
| AU2016319010A8 (en) | In vitro method for identifying a pregnancy related disease | |
| GB201612427D0 (en) | Selecting equity investments using quantitative multi-factor models | |
| EP3688471A4 (en) | FORECAST PROCEDURE | |
| MX2018004005A (es) | Ensayo de potencia celular. | |
| MX2016010499A (es) | Sistemas y métodos para identificar subtipos del receptor de progesterona. | |
| MX2016003248A (es) | Metodos de uso de anticuerpos anti-lgr5. | |
| IN2014CH00466A (OSRAM) |